EXUMA Biotech Email Format
Biotechnology ResearchFlorida, United States11-50 Employees
EXUMA Biotech is a clinical-stage biotechnology company developing next-generation in vivo cell and gene therapies. Founded in 2015 and headquartered in West Palm Beach, Florida, it operates across the Cayman Islands and Asia, pursuing a globally integrated approach to science and development. The company aims to create safe, effective, and accessible therapies that remove traditional barriers to CAR-T treatment, leveraging platforms that support high-throughput discovery, tumor-specific targeting, and point-of-care delivery. EXUMA operates in the biotechnology research sector, focusing on CAR-T and related in vivo cell and gene therapies for cancer. Its work is aimed at patients and healthcare providers seeking safer, more accessible CAR-T options, including autologous programs and solid-tumor indications. A recent development is the announcement of Phase 1 results for an autologous HER2-directed, tumor metabolism-regulated CAR-T product at ASCO GI 2025.